# Impact of maternal hypothyroidism on human milk macronutrient content and fatty acid composition: a prospective cohort study

**Authors:** Shahad Alodhaybi, Manal Abdulaziz Binobaed, Rasha Homoud AlAnazi, Nora Elwehedy, Muneera Baraja, Fatimah Yousef Aljawoan, Waleed Tamimi, Lamia Mohammed Elamin, Azza Madkhali

PMC · DOI: 10.3389/fnut.2026.1769344 · Frontiers in Nutrition · 2026-02-10

## TL;DR

This study found that maternal hypothyroidism, even when treated, is linked to changes in the fatty acid composition of human milk, which could affect infant nutrition.

## Contribution

The study is the first to show specific fatty acid changes in human milk from mothers with hypothyroidism, even with treatment.

## Key findings

- Maternal hypothyroidism was associated with higher levels of docosapentaenoic acid and elaidic acid in human milk.
- Lower levels of tricosanoic acid were observed in milk from mothers with hypothyroidism.
- Changes in milk fatty acids may reflect altered lipid metabolism due to thyroid hormone imbalances.

## Abstract

Hypothyroidism can alter the serum lipid profile and the composition of human milk (HM) proteins involved in macronutrient metabolism. We investigated the association between maternal hypothyroidism and HM macronutrient content and fatty acid (FA) composition.

In this prospective cohort study conducted in Riyadh, Saudi Arabia, HM samples from mothers with hypothyroidism (n = 19) and mothers without hypothyroidism (n = 30) were compared. Eligible participants were breastfeeding mothers of term singleton infants with no history of metabolic disorders or chronic disease. Maternal demographic characteristics, anthropometrics, laboratory markers, dietary intake, and HM samples were collected 4–13 weeks postpartum. Primary outcomes were HM macronutrient content and FA composition, analyzed using the Miris HM analyzer and gas chromatography–flame ionization detection, respectively.

Forty-nine participants were recruited between December 12, 2023, and May 31, 2025. HM macronutrient content and total saturated, monounsaturated, polyunsaturated, and trans FAs (TFAs) did not differ between groups. Among mothers with hypothyroidism, 10 individual FA species differed significantly (eight higher and two lower), characterized by higher industrial TFAs and selected long-chain omega-3 and omega-6 species. Mothers with hypothyroidism had higher levels of docosapentaenoic acid (0.079 ± 0.024% vs. 0.063 ± 0.024%) and elaidic acid (0.286% [0.233–0.439%] vs. 0.118% [0.028–0.220%]), but lower levels of tricosanoic acid (0.00% [0.00–0.00%] vs. 0.011% [0.00–0.022%]) (all p < 0.05). They also had higher low-density lipoprotein cholesterol (3.45 [2.87–3.97] vs. 2.94 [2.35–3.32] mmol/L; p = 0.01), whereas other lipid parameters did not differ significantly.

Maternal hypothyroidism, even when treated with replacement therapy, was associated with altered HM FA composition. These changes may reflect thyroid hormone–related shifts in lipid metabolism, potentially influenced by maternal diet and adipose stores. Future longitudinal research is needed to investigate whether integrating thyroid-aware lactation support and targeted nutritional interventions can effectively modulate these effects and improve breastfeeding outcomes.

## Linked entities

- **Chemicals:** docosapentaenoic acid (PubChem CID 5497182), elaidic acid (PubChem CID 637517), tricosanoic acid (PubChem CID 17085)
- **Diseases:** hypothyroidism (MONDO:0005420)

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, LIPC (lipase C, hepatic type) [NCBI Gene 3990] {aka HDLCQ12, HL, HTGL}
- **Diseases:** hypertension (MESH:D006973), Hypothyroidism (MESH:D007037), Chronic inflammation (MESH:D007249), diabetes (MESH:D003920), HM (MESH:D016269), preterm birth (MESH:D047928), overweight (MESH:D050177), systemic (MESH:D015619), allergic manifestations (MESH:D004342), GD (MESH:D005776), GDM (MESH:D016640), obese (MESH:D009765), adiposity (MESH:D018205), thyroid dysfunction (MESH:D013959), chronic diseases (MESH:D002908), Maternal (MESH:D000079262), lipid (MESH:D011017), metabolic dysregulation (MESH:D021081), metabolic (MESH:D008659)
- **Chemicals:** TC (MESH:D013667), PUFA (MESH:D005231), elaidic acid (MESH:C011459), linoleic acid (MESH:D019787), methanol (MESH:D000432), palmitelaidic acid (MESH:C008757), helium (MESH:D006371), C22:5 n-3 (MESH:C026219), C11:0 (-), Euthyrox (MESH:D013974), FAT (MESH:D005223), MUFA (MESH:D005229), FA (MESH:D005227), carbohydrate (MESH:D002241), essential fatty acid (MESH:D005228), TG (MESH:D014280), n-heptane (MESH:C028618), KOH (MESH:C029943), palmitic acid (MESH:D019308), DHA (MESH:D004281), Lipid (MESH:D008055), ALA (MESH:D017962), Tricosanoic acid (MESH:C068166), heneicosanoic acid (MESH:C517970), LA (MESH:D007811), water (MESH:D014867), C20:5 n-3 (MESH:D015118), undecanoic acid (MESH:C016173), sulfuric acid (MESH:C033158), TFA (MESH:D044242), cholesterol (MESH:D002784), vaccenic acid (MESH:C050413), T3 (MESH:D014284), Oleic acid (MESH:D019301)
- **Species:** Homo sapiens (human, species) [taxon 9606], Scombridae gen. sp. (tuna, species) [taxon 8233], Rubroshorea almon (species) [taxon 292004]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929449/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929449/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929449/full.md

---
Source: https://tomesphere.com/paper/PMC12929449